Drug & Supplement Interactions

Cha De Bugre + Obinutuzumab

Brand name of Obinutuzumab

  • Gazyva

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated June 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Cha De Bugre and Obinutuzumab in our sources.

This also applies to Gazyva, a brand name of obinutuzumab.

Still Worth Knowing

  • Food rule: The label for Obinutuzumab states a food rule worth keeping to.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Cha De Bugre with Obinutuzumab. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Cha De Bugre and Obinutuzumab Interaction Check

No Known Interaction Found

We did not find a documented interaction between Obinutuzumab and Cha De Bugre in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for Obinutuzumab

Neither one has a record. Our interaction database holds no record for Cha De Bugre with any drug, and none for Obinutuzumab with any supplement, so this rests on missing data, not on a study that found nothing.

Still wondering about combining Cha De Bugre and Obinutuzumab? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share

Before You Combine Them

Taking Cha De Bugre and Obinutuzumab Together

What to Watch For

What Obinutuzumab’s Own FDA Label Lists

  • This is not an interaction: none of it involves Cha De Bugre.
  • These are the most notable effects listed in the Adverse Reactions section of Obinutuzumab’s own FDA label, for the medication by itself.
  • Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both.
  • 10 of them are worth acting on rather than waiting out, marked below.
  • High potassium Worth Acting On
  • Low sodium Worth Acting On
  • Low potassium Worth Acting On
  • A low platelet count Worth Acting On
  • Kidney problems Worth Acting On
  • Anemia Worth Acting On
  • A low white blood cell count Worth Acting On
  • Liver problems Worth Acting On
  • A higher chance of infection Worth Acting On
  • An allergic reaction Worth Acting On

Showing the 10 most notable of 17 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the Adverse Reactions section of the FDA label for Obinutuzumab. Read the label on DailyMed › We found no side effects in Cha De Bugre’s licensed record to compare with these. That is a limit of the record, not a statement that Cha De Bugre has no side effects.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.
How to Take Them

Some Obinutuzumab Products Have a Food Rule — Cha De Bugre Should Not Break It

At least one FDA label for a product containing Obinutuzumab says to take it on an empty stomach. Most supplements — Cha De Bugre included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Obinutuzumab on its own and move Cha De Bugre to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Obinutuzumab products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

650–1,000 mg acetaminophen At least 30 minutes before GAZYVA infusion.

From the Dosage and Administration section of the FDA label we read for Obinutuzumab — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

One More Smart Check

Taking Cha De Bugre as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Cha De Bugre. We have broken down 62 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Obinutuzumab:

Get to Know Each One

About Cha De Bugre and Obinutuzumab

Supplement

About Cha De Bugre

Cha De Bugre is a Brazilian herbal tea traditionally used for weight loss and appetite control, but solid human research supporting these uses is lacking. Because it may have caffeine-like stimulant effects and its safety has not been well studied, talk with your pharmacist or doctor before trying it, and avoid it during pregnancy and breastfeeding.

Full Cha De Bugre guide: uses, dosage, safety and every interaction
Safety at a Glance

How Cha De Bugre Is Rated

  • Cha De Bugre Overall

    Use caution

    Limited human safety data and possible stimulant effects mean it should be used cautiously.

  • Pregnancy

    Avoid

    Not enough safety information, so it is best avoided during pregnancy.

  • Breastfeeding

    Avoid

    Safety while breastfeeding is unknown, so avoid use.

Medication

About Obinutuzumab Injection

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Cha De Bugre

Browse every other medication we’ve checked against Cha De Bugre — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No Interaction 2,829 drugs checked — show the list

We also checked Cha De Bugre against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 2,829 medications checked with no known interaction, the most looked-up first — see the full Cha De Bugre list.

How Much People Look This Up

Where Cha De Bugre and Obinutuzumab Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cha De Bugre
Steady interest

#863 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Obinutuzumab
Top half

#1,064 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Cha De Bugre and Obinutuzumab Together: Common Questions

Can you take Cha De Bugre with Obinutuzumab?
We do not list a known interaction between Cha De Bugre and Obinutuzumab. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Cha De Bugre with Gazyva?
Gazyva is a brand name of obinutuzumab, so the answer is the same as for obinutuzumab. We do not list a known interaction between Cha De Bugre and Obinutuzumab. Everything on this page applies to Gazyva too.
Should I take Cha De Bugre and Obinutuzumab at the same time of day?
At least one FDA label for a product containing Obinutuzumab says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Obinutuzumab on its own and move Cha De Bugre to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

We checked Cha De Bugre against Obinutuzumab in the Natural Medicines interaction database and found no documented interaction on file. The medication overview comes from MedlinePlus, and supplement label details from the NIH Dietary Supplement Label Database.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources.
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Cha De Bugre and Obinutuzumab records this page draws on were last updated June 22, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Cha De Bugre and Obinutuzumab?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.